Cargando…
CE‐MS for metabolomics: Developments and applications in the period 2016–2018
In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586046/ https://www.ncbi.nlm.nih.gov/pubmed/30232802 http://dx.doi.org/10.1002/elps.201800323 |
_version_ | 1783428827390672896 |
---|---|
author | Ramautar, Rawi Somsen, Govert W. de Jong, Gerhardus J. |
author_facet | Ramautar, Rawi Somsen, Govert W. de Jong, Gerhardus J. |
author_sort | Ramautar, Rawi |
collection | PubMed |
description | In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for (large‐scale) metabolic profiling studies and for establishing protocols in order to further expand the role of CE‐MS in metabolomics. In this paper, which is a follow‐up of a previous review paper covering the years 2014–2016 (Electrophoresis 2017, 38, 190–202), main advances in CE‐MS approaches for metabolomics studies are outlined covering the literature from July 2016 to June 2018. Aspects like developments in interfacing designs and data analysis tools for improving the performance of CE‐MS for metabolomics are discussed. Representative examples highlight the utility of CE‐MS in the fields of biomedical, clinical, microbial, and plant metabolomics. A complete overview of recent CE‐MS‐based metabolomics studies is given in a table, which provides information on sample type and pretreatment, capillary coatings and MS detection mode. Finally, some general conclusions and perspectives are given. |
format | Online Article Text |
id | pubmed-6586046 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65860462019-06-27 CE‐MS for metabolomics: Developments and applications in the period 2016–2018 Ramautar, Rawi Somsen, Govert W. de Jong, Gerhardus J. Electrophoresis Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids In the field of metabolomics, CE‐MS is now recognized as a strong analytical technique for the analysis of (highly) polar and charged metabolites in a wide range of biological samples. Over the past few years, significant attention has been paid to the design and improvement of CE‐MS approaches for (large‐scale) metabolic profiling studies and for establishing protocols in order to further expand the role of CE‐MS in metabolomics. In this paper, which is a follow‐up of a previous review paper covering the years 2014–2016 (Electrophoresis 2017, 38, 190–202), main advances in CE‐MS approaches for metabolomics studies are outlined covering the literature from July 2016 to June 2018. Aspects like developments in interfacing designs and data analysis tools for improving the performance of CE‐MS for metabolomics are discussed. Representative examples highlight the utility of CE‐MS in the fields of biomedical, clinical, microbial, and plant metabolomics. A complete overview of recent CE‐MS‐based metabolomics studies is given in a table, which provides information on sample type and pretreatment, capillary coatings and MS detection mode. Finally, some general conclusions and perspectives are given. John Wiley and Sons Inc. 2018-10-01 2019-01 /pmc/articles/PMC6586046/ /pubmed/30232802 http://dx.doi.org/10.1002/elps.201800323 Text en © 2018 The Authors. Electrophoresis Published by WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids Ramautar, Rawi Somsen, Govert W. de Jong, Gerhardus J. CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title | CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title_full | CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title_fullStr | CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title_full_unstemmed | CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title_short | CE‐MS for metabolomics: Developments and applications in the period 2016–2018 |
title_sort | ce‐ms for metabolomics: developments and applications in the period 2016–2018 |
topic | Part III. Applications: Biomarkers, Proteomics, Metabolomics, Biomedical and Lipids |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586046/ https://www.ncbi.nlm.nih.gov/pubmed/30232802 http://dx.doi.org/10.1002/elps.201800323 |
work_keys_str_mv | AT ramautarrawi cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018 AT somsengovertw cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018 AT dejonggerhardusj cemsformetabolomicsdevelopmentsandapplicationsintheperiod20162018 |